Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model.

Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model. Antiviral Res. 2018 Jan 21;: Authors: Zhu W, Zhang Z, He S, Wong G, Banadyga L, Qiu X Abstract Filoviruses, such as Marburg and Ebola viruses, cause severe disease in humans with high case fatality rates and are therefore considered biological threat agents. To date, no licensed vaccine or therapeutic exists for their treatment. T-705 (favipiravir) is a pyrazinecarboxamide derivative that has shown broad antiviral activity against a number of viruses and is clinically licenced in Japan to treat influenza. Here we report the efficacy of T-705 against Marburg virus infection in vitro and in vivo. Notably, oral administration of T-705 beginning one or two days post-infection and continuing for eight days resulted in complete survival of mice that had been intraperitoneally infected with mouse-adapted Marburg virus (variant Angola). Moreover, lower doses of T-705 and higher doses administered later during infection (day 3 or 4 post-infection) showed partial efficacy, with at least half the infected mice surviving. Accordingly, we observed reductions in infectious virus particles and virus RNA levels following drug treatment that appeared to correlate with survival. Our findings suggest that T-705 may be an effective therapeutic against Marburg virus and might be especially promising for use in the event of an outbreak, where it could be orally administered q...
Source: Antiviral Research - Category: Virology Authors: Tags: Antiviral Res Source Type: research

Related Links:

Severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2), the cause of coronavirus disease 2019 (COVID-19), has spurred a global health crisis. To date, there are no proven options for prophylaxis for those who have been exposed to SARS–CoV-2, nor therapy for those who develop COVID-19. Immune (i.e., “convalescent”) plasma refers to plasma that is collected from individuals following resolution of infection and development of antibodies. Passive antibody administration through transfusion of convalescent plasma may offer the only short-term strategy for conferring immediate immunity to susceptib...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
Dr Fauci says he hasn ’t spoken to Trump in two weeks; New Zealand to consider easing restrictions earlier than planned; Mexico deaths pass 10,000. Follow the latest updatesSingapore reopens schoolsUK: Critics round on No 10 over ‘ridiculous’ rules for 14-day quarantineAustralia coronavirus updates – liveCoronavirus latest: at a glanceSee all our coronavirus coverage6.46amBSTTheAssociated Pressis carrying a report that says Chinese officials sat on releasing the genetic map, or genome, of the coronavirus for over a week after multiple government labs had fully decoded it, not sharing details key to ...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak World news Infectious diseases Science Microbiology Medical research UK news US news Australia news Source Type: news
Emmie de Wit joins TWiV to explain her work on the pathogenesis of infection with SARS-CoV-2 in rhesus macaques, including studies on remdesivir and vaccine candidate. Hosts: Vincent Racaniello, Rich Condit, and Brianne Barker Guest: Emmie de Wit Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Respiratory disease in macaques inoculated with SARS-CoV-2 (Nature) Clinical benefit of remdesivir in SARS-CoV-2 infected macaques (bioRxiv) Remdesivir for MERS-CoV infection in macaques (PNAS) ChAdOX1 vaccination for SARS-CoV-2 in macaques ...
Source: This Week in Virology - MP3 Edition - Category: Virology Authors: Source Type: podcasts
[WHO] Geneva/Brazzaville/Kinshasa -The Government of the Democratic Republic of the Congo (DRC) announced today that a new outbreak of Ebola virus disease is occurring in Wangata health zone, Mbandaka, in Équateur province. The announcement comes as a long, difficult and complex Ebola outbreak in eastern DRC is in its final phase, while the country also battles COVID-19 and the world's largest measles outbreak.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
[RFI] Five new cases of Ebola have been declared in the north-western region of the Democratic Republic of Congo, according to Health Minister Eteni Longondo, who said four of the five cases had already died.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
[DW] Following four deaths in western Congo, 1,000km from the ongoing outbreak, authorities have reported a new Ebola epidemic. "COVID-19 is not the only health threat people face," WHO chief Tedros said.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
Ian Sample talks to Prof Carl Heneghan about the uncertainties in predicting future outbreaks of Covid-19 and what we can do to prevent themContinue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Science Coronavirus outbreak Infectious diseases Medical research Microbiology World news Health Society Source Type: news
Hi all, The CDC recommends the first immunization for live vaccines (s.a. MMR, Varicella) begin at 12 months of age. However, rotavirus is also a live vaccine but is administered at 2, 4, and 6 months, and is never administered after 8 months. I know that the rotavirus vaccine decreases the severity of illness if it is contracted and prevents most rotavirus cases in the US, but theoretically, why would this work before the immune system has matured enough?
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Clinical Rotations Source Type: forums
Five people, including a 15-year-old girl, have died of Ebola in a fresh outbreak of the virus in the Democratic Republic of Congo, the United Nations Children's Fund said Monday. Nine cases total have been reported, UNICEF said.
Source: - Health - Category: Consumer Health News Source Type: news
Much remains unknown and mysterious, but these are some of the things we ’re pretty sure of after half a year of this pandemic.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus (2019-nCoV) Coronavirus Reopenings Research Medicine and Health Science and Technology Vaccination and Immunization Quarantines Masks Tests (Medical) Antibodies Protective Clothing and Gear your-feed-science your-feed-h Source Type: news
More News: Angola | Ebola | Ebola Vaccine | Filovirus | Influenza | Influenza Vaccine | Japan Health | Marburg Virus | Outbreaks | Vaccines | Virology